[1] Wu SM, Wu B, Liu M, et al.Stroke in China: advances and challenges in epidemiology, prevention, and management[J].Lancet Neurol, 2019, 18(4):394-405. [2] Krishnamurthi RV, Ikeda T, Feigin VL.Global, regional and country-specific burden of ischaemic stroke, intracerebral haemorrhage and subarachnoid haemorrhage: a systematic analysis of the global burden of disease study 2017[J].Neuroepidemiology, 2020,54(2):171-179. [3] 霍晓川,高峰.急性缺血性卒中血管内治疗中国指南2018[J].中国卒中杂志,2018,13(7):706-729. [4] Huttner HB, Schwab S.Malignant middle cerebral artery infarction: clinical characteristics, treatment strategies, and future perspectives[J].Lancet Neurol, 2009,8(10):949-958. [5] Rai AT, Domico JR, Buseman C, et al.A population-based incidence of M2 strokes indicates potential expansion of large vessel occlusions amenable to endovascular therapy[J].J Neurointerv Surg, 2018,10(6):510-515. [6] Mokin M, Fargen KM, Primiani CT, et al.Vessel perforation during stent retriever thrombectomy for acute ischemic stroke: technical details and clinical outcomes[J].J Neurointerv Surg, 2017,9(10):922-928. [7] Eskey CJ, Meyers PM, Nguyen TN, et al.Indications for the performance of intracranial endovascular neurointerventional procedures: a scientific statement from the American heart association[J].Circulation, 2018,137(21):e661-e689. [8] 国家卫生健康委脑卒中防治工程委员会,中华医学会神经外科学分会神经介入学组,中华医学会放射学分会介入学组,等.急性大血管闭塞性缺血性卒中血管内治疗中国专家共识(2019年修订版)[J].中华神经外科杂志,2019,35(9):868-879. [9] Hermann DM, Popa-Wagner A, Kleinschnitz C, et al.Animal models of ischemic stroke and their impact on drug discovery[J].Expert Opin Drug Discov, 2019,14(3):315-326. [10] Fluri F, Schuhmann MK, Kleinschnitz C.Animal models of ischemic stroke and their application in clinical research[J].Drug Des Devel Ther, 2015,9:3445-3454. [11] Gao X, Zhang XJ, Cui LL, et al.Ginsenoside Rb1 promotes motor functional recovery and axonal regeneration in post-stroke mice through cAMP/PKA/CREB signaling pathway[J].Brain Res Bull, 2020,154:51-60. [12] Candelario-Jalil E, Paul S.Impact of aging and comorbidities on ischemic stroke outcomes in preclinical animal models: a translational perspective[J].Exp Neurol, 2021,335:113494. [13] Zuo XL, Hu SQ, Tang YY, et al.Attenuation of secondary damage and Aβ deposits in the ipsilateral thalamus of dMCAO rats through reduction of cathepsin B by bis(propyl)-cognitin, a multifunctional dimer[J].Neuropharmacology, 2020,162:107786. [14] Kuraoka M, Furuta T, Matsuwaki T, et al.Direct experimental occlusion of the distal middle cerebral artery induces high reproducibility of brain ischemia in mice[J].Exp Anim, 2009,58(1):19-29. [15] Llovera G, Roth S, Plesnila N, et al.Modeling stroke in mice: permanent coagulation of the distal middle cerebral artery[J].J Vis Exp, 2014, (89):e51729. [16] Mekada K, Abe K, Murakami A, et al.Genetic differences among C57BL/6 substrains[J].Exp Anim, 2009,58(2):141-149. [17] Doyle K P, Buckwalter MS.A mouse model of permanent focal ischemia: distal middle cerebral artery occlusion[J].Methods Mol Biol, 2014,1135:103-110. [18] Tamura A, Graham DI, Mcculloch J, et al.Focal cerebral ischaemia in the rat: 1.Description of technique and early neuropathological consequences following middle cerebral artery occlusion[J].J Cereb Blood Flow Metab, 1981,1(1):53-60. [19] Majid A, He YY, Gidday JM, et al.Differences in vulnerability to permanent focal cerebral ischemia among 3 common mouse strains[J].Stroke, 2000,31(11):2707-2714. [20] 孔德莲,管樟萌,祖洁,等.小鼠大脑中动脉近端及远端阻塞脑缺模型比较[J].中西医结合心血管病电子杂志,2018,6(25):173-175. [21] Brott T, Marler JR, Olinger CP, et al.Measurements of acute cerebral infarction: lesion size by computed tomography[J].Stroke, 1989,20(7):871-875. [22] Heinsius T, Bogousslavsky J, Van Melle G.Large infarcts in the middle cerebral artery territory.Etiology and outcome patterns[J].Neurology, 1998,50(2):341-350. |